We examined the effect of Angiotensin II (Ang II) on the interaction between the Ca2+/CaM complex and hNHE1. Considering that calmodulin binds to NHE1 at two sites (A and B), amino acids at both sites were modified and two mutants were constructed: SA1K3R/4E and SB1K3R/4E. Wild type and mutants were transfected into PS120 cells and their activity was examined by H+ flux (JH+). The basal JH+ of wild type was 4.71 ± 0.57 (mM/min), and it was similar in both mutants. However, the mutations partially impaired the binding of CaM to hNHE1. Ang II (10-12 and 10-9 M) increased the JH+ in wild type and SB. Ang II (10-6 M) increased this parameter only in SA. Ang II (10-9 M) maintained the expression of calmodulin in wild type or mutants, and Ang II (10-6 M) decreased it in wild type or SA, but not in SB. Dimethyl-Bapta-AM (10-7 M), a calcium chelator, suppressed the effect of Ang II (10-9 M) in wild type. With Ang II (10-6 M), Bapta failed to affect wild type or SA, but it increased the JH+ in SB. W13 or calmidazolium chloride (10-5 M), two distinct calmodulin inhibitors, decreased the effect of Ang II (10-9 M) in wild type or SB. With Ang II (10-6 M), W13 or calmidazolium chloride decreased the JH+ in wild type or SA and increased it in SB. Thus, with Ang II (10-12 and 10-9 M), site A seems to be responsible for the stimulation of hNHE1 and with Ang II (10-6 M), site B is important to maintain its basal activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.